US Drug Recall Register

Is Chloride recalled?

Yes — there is an active recall. 326 ongoing FDA recalls mention Chloride (1,994 total). Check the affected lots below.

Recalls are matched by product description. A recall usually affects specific lots, not every package of Chloride. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed.

Class II · Moderate risk Terminated

Ranitidine Hydrochloride

Reason CGMP Deviations: Presence of NDMA impurity detected in product.

Spectrum Laboratory Products D-0825-2020
Class II · Moderate risk Terminated

ranitidine hydrochloride

Reason CGMP Deviations: Received notice from supplier of potential -Nitrosodimethylamine (NDMA) amounts above established levels.

PD-Rx Pharmaceuticals, Inc. NDC 43063-844-14 D-0826-2020
Class III · Low risk Terminated

Proparacaine Hydrochloride Ophthalmic Solution

Reason Chemical contamination; out of specification results obtained for equipment cleaning residue rinse sample

Akorn, Inc. NDC 17478-263-12 D-1388-2020
Class III · Low risk Terminated

Memantine Hydrochloride Extended-release Capsules

Reason Failed Dissolution Specifications: High out of specification result observed at stability studies.

The Harvard Drug Group NDC 0904-6735-61 D-0844-2020
Class III · Low risk Terminated

Memantine Hydrochloride Extended-release Capsules

Reason Failed Dissolution Specifications: High out of specification result observed at stability studies.

Lupin Pharmaceuticals Inc. NDC 68180-249-09 D-0629-2020
Class II · Moderate risk Terminated

Raloxifene Hydrochloride Tablets

Reason Failed Dissolution Specifications: Low out of specification results obtained during stability testing.

American Health Packaging D-0854-2020
Class II · Moderate risk Terminated

Amantadine Hydrochloride Tablets

Reason Presence of Foreign Substance: Presence of a foreign object in a single tablet.

Jubilant Cadista Pharmaceuticals, Inc. NDC 59746-699-01 D-0576-2020
Class II · Moderate risk Terminated

Vancomycin Hydrochloride for Injection

Reason Discoloration: Product complaints of discoloration after reconstitution of vials.

AuroMedics Pharma LLC NDC 55150-204-20 D-0574-2020
Class II · Moderate risk Terminated

fentaNYL 550 mcg/55 mL

Reason Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

QuVa Pharma, Inc. NDC 70092-1274-50 D-0572-2020
Class II · Moderate risk Terminated

fentaNYL 1000 mcg/100 mL

Reason Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

QuVa Pharma, Inc. NDC 70092-1250-75 D-0571-2020
Class II · Moderate risk Terminated

fentaNYL 800 mcg/200 mL

Reason Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

QuVa Pharma, Inc. NDC 70092-1436-76 D-0568-2020
Class II · Moderate risk Terminated

fentaNYL 1250 mcg/250 mL

Reason Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

QuVa Pharma, Inc. NDC 70092-1444-05 D-0567-2020
Class II · Moderate risk Terminated

fentaNYL 200 mcg/100 mL

Reason Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

QuVa Pharma, Inc. NDC 70092-1103-36 D-0565-2020
Class II · Moderate risk Terminated

fentaNYL 400 mcg/200 mL

Reason Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

QuVa Pharma, Inc. NDC 70092-1441-76 D-0564-2020
Class II · Moderate risk Terminated

fentaNYL 2000 mcg/100 mL

Reason Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

QuVa Pharma, Inc. NDC 70092-1094-36 D-0563-2020
Class II · Moderate risk Terminated

fentaNYL 400 mcg/200 mL

Reason Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

QuVa Pharma, Inc. NDC 70092-1207-37 D-0562-2020
Class II · Moderate risk Terminated

fentaNYL 200 mcg/100 mL

Reason Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

QuVa Pharma, Inc. NDC 70092-1108-36 D-0561-2020
Class II · Moderate risk Terminated

fentaNYL 200 mcg/100 mL

Reason Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

QuVa Pharma, Inc. NDC 70092-1255-75 D-0559-2020
Class II · Moderate risk Terminated

fentaNYL 200 mcg/100 mL

Reason Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

QuVa Pharma, Inc. NDC 70092-1202-75 D-0557-2020
Class II · Moderate risk Terminated

fentaNYL 1000 mcg/100 mL

Reason Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

QuVa Pharma, Inc. NDC 70092-1092-36 D-0555-2020
Class II · Moderate risk Terminated

fentaNYL 400 mcg/200 mL

Reason Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules

QuVa Pharma, Inc. NDC 70092-1440-76 D-0554-2020